Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Janssen reports long-term data from tremfya trial

VOYAGE 1 evaluated subcutaneous tremfya for moderate to severe plaque psoriasis. Credit: Hush Naidoo on Unsplash.

  • Injection

Go Top